MedPharm, Ltd. and Tergus Pharma Merger Forms Topical and Transepithelial CDMO Leader
GUILDFORD, United Kingdom and DURHAM, N.C., July 8, 2024 — MedPharm, Ltd., an Ampersand Capital Partners portfolio company, and Tergus Pharma, a Great Point Partners [...]
Tergus Pharma Announces Michael Kane as Chief Executive Officer
Durham, NC – Tergus Pharma, a commercial scale Contract Development and Manufacturing Organization (CDMO) of semi-solid and liquid dosage forms, [...]
Tergus Pharma Makes Key Executive Hires
DURHAM, N.C. September 8, 2021 — Tergus Pharma, the leading topical Contract Development and Manufacturing Organization (CDMO) with proven topical [...]
Tergus Pharma to Participate in ECRM Contract Services Program for OTC Health and Supplements
DURHAM, N.C. February 9, 2021 – Tergus Pharma announced today that the company will be participating in ECRM’s virtual trade [...]